Vezakis Antonios, Fragulidis Georgios, Polydorou Andreas
Antonios Vezakis, Georgios Fragulidis, Andreas Polydorou, Academic Department of Surgery and Endoscopy Unit, University of Athens, Aretaieion Hospital, 11528 Athens, Greece.
World J Gastrointest Endosc. 2015 Oct 10;7(14):1135-41. doi: 10.4253/wjge.v7.i14.1135.
Endoscopic retrograde cholangiopancreatography (ERCP) has become an important therapeutic modality for biliary and pancreatic disorders. Perforation is one of the most feared complications of ERCP and endoscopic sphincterotomy. A MEDLINE search was performed from 2000-2014 using the keywords "perforation", "ERCP" and "endoscopic sphincterotomy". All articles including more than nine cases were reviewed. The incidence of ERCP-related perforations was low (0.39%, 95%CI: 0.34-0.69) with an associated mortality of 7.8% (95%CI: 3.80-13.07). Endoscopic sphincterotomy was responsible for 41% of perforations, insertion and manipulations of the endoscope for 26%, guidewires for 15%, dilation of strictures for 3%, other instruments for 4%, stent insertion or migration for 2% and in 7% of cases the etiology was unknown. The diagnosis was made during ERCP in 73% of cases. The mechanism, site and extent of injury, suggested by clinical and radiographic findings, should guide towards operative or non-operative management. In type I perforations early surgical repair is indicated, unless endoscopic closure can be achieved. Patients with type II perforations should be treated initially non-operatively. Non-operative treatment includes biliary stenting, fasting, intravenous fluid resuscitation, nasogastric drainage, broad spectrum antibiotics, percutaneous drainage of fluid collections. Non-operative treatment was successful in 79% of patients with type II injuries, with an overall mortality of 9.4%. Non-operative treatment was sufficient in all patients with type III injuries. Surgical technique depends on timing, site and size of defect and clinical condition of the patient. In conclusion, diagnosis is based on clinical suspicion and clinical and radiographic findings. Whilst surgery is usually indicated in patients with type I injuries, patients with type II or III injuries should be treated initially non-operatively. A minority of them will finally require surgical intervention.
内镜逆行胰胆管造影术(ERCP)已成为治疗胆管和胰腺疾病的一种重要治疗方式。穿孔是ERCP和内镜括约肌切开术最可怕的并发症之一。利用关键词“穿孔”“ERCP”和“内镜括约肌切开术”对2000年至2014年期间的医学文献数据库(MEDLINE)进行了检索。对所有包含超过9例病例的文章进行了综述。ERCP相关穿孔的发生率较低(0.39%,95%置信区间:0.34 - 0.69),相关死亡率为7.8%(95%置信区间:3.80 - 13.07)。内镜括约肌切开术导致41%的穿孔,内镜插入和操作导致26%,导丝导致15%,狭窄扩张导致3%,其他器械导致4%,支架置入或移位导致2%,7%的病例病因不明。73%的病例在ERCP过程中做出诊断。临床和影像学检查结果提示的损伤机制、部位和程度,应指导手术或非手术治疗。对于I型穿孔,除非能实现内镜闭合,否则应尽早进行手术修复。II型穿孔患者应首先进行非手术治疗。非手术治疗包括胆管支架置入、禁食、静脉补液、鼻胃管引流、广谱抗生素、经皮穿刺引流积液。79%的II型损伤患者非手术治疗成功,总体死亡率为9.4%。所有III型损伤患者非手术治疗均足够。手术技术取决于穿孔的时间、部位、大小以及患者的临床状况。总之,诊断基于临床怀疑以及临床和影像学检查结果。虽然I型损伤患者通常需要手术治疗,但II型或III型损伤患者应首先进行非手术治疗。其中少数患者最终将需要手术干预。